Diagnosis and treatment of Helicobacter pylori infection

Danish Medical Bulletin

Volumn 58, Issue 4, 2011, Pages

  Bytzer, Peter ^a   Dahlerup, Jens Frederik ^a   Eriksen, Jens Ravn ^a   Jarbøl, Dorte ^a   Rosenstock, Steffen ^a   Wildt, Signe ^a  

^a KØGE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH SALICYLATE; CLARITHROMYCIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; TETRACYCLINE; ANTIDIARRHEAL AGENT; ANTIINFECTIVE AGENT; BISMUTH; ORGANOMETALLIC COMPOUND; SALICYLIC ACID DERIVATIVE;

ANTIGEN DETECTION; ARTICLE; DYSPEPSIA; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; PEPTIC ULCER; PRACTICE GUIDELINE; STOMACH CANCER; TREATMENT FAILURE; TREATMENT INDICATION; UREA BREATH TEST; DENMARK; DRUG COMBINATION; ISOLATION AND PURIFICATION; MARGINAL ZONE LYMPHOMA; REVIEW; STOMACH TUMOR;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTIDIARRHEALS; BISMUTH; CLARITHROMYCIN; DENMARK; DRUG THERAPY, COMBINATION; DYSPEPSIA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; METRONIDAZOLE; ORGANOMETALLIC COMPOUNDS; PEPTIC ULCER; PROTON PUMP INHIBITORS; SALICYLATES; STOMACH NEOPLASMS; TETRACYCLINE;

EID: 79955154182     PISSN: 16039629     EISSN: 16039629     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Axon A, Forman D. Helicobacter gastroduodenitis: a serious infectious disease. BMJ 1997;314:1430.
2. Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007;102:1808-25.
3. Malfertheiner P, Megraud F, O'Morain C et al. Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002;16:167-80.
4. Malfertheiner P, Megraud F, O'Morain C et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-81.
5. Søndergaard B, Bytzer P. H pylori infection is no longer the major cause of peptic ulcer in Copenhagen County. Gastroenterology 2006;130(suppl 2):A268.
6. Bytzer P, Teglbjærg PS, Danish Ulcer Study Group. Helicobacter pylori-negative duodenal ulcers: Prevalence, clinical characteristics and prognosis - Results from a clinical trial with 2 year follow-up. Am J Gastroenterol 2001;96:1409-16.
7. Rosenstock SJ, Jorgensen T, Bonnevie O et al. Does Helicobacter pylori infection explain all socio-economic differences in peptic ulcer incidence? Genetic and psychosocial markers for incident peptic ulcer disease in a large cohort of Danish adults. Scand J Gastroenterol 2004;39:823-9.
8. Aro P, Storskrubb T, Ronkainen J et al. Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol 2006;163:1025-34.
9. Gisbert JP, Khorrami S, Carballo F et al. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Aliment Pharmacol Ther 2004;19:617-29.
10. Gisbert JP, Calvet X, Feu F et al. Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding. Helicobacter 2007;12:279-86.
11. El-Nakeeb A, Fikry A, bd El-Hamed TM et al. Effect of Helicobacter pylori eradication on ulcer recurrence after simple closure of perforated duodenal ulcer. Int J Surg 2009;7:126-9.
12. Ford AC, Qume M, Moayyedi P et al. Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis. Gastroenterology 2005;128:1838-44.
13. Delaney B, Ford AC, Forman D et al. Initial management strategies for dyspepsia. Cochrane Database Syst Rev 2005; CD001961.
14. Delaney BC, Qume M, Moayyedi P et al. Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial). BMJ 2008;336:651-4.
15. Jarbol DE, Kragstrup J, Stovring H et al. Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial. Am J Gastroenterol 2006;101:1200-8.
16. Ford AC, Moayyedi P, Jarbol DE et al. Meta-analysis: Helicobacter pylori'test and treat' compared with empirical acid suppression for managing dyspepsia. Aliment Pharmacol Ther 2008;28:534-44.
17. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002;359:14-22.
18. Gabriel S, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. Ann Intern Med 1991;115:787-96.
19. Vergara M, Catalan M, Gisbert JP et al. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Ther 2005;21:1411-8.
20. Muhsen K, Cohen D. Helicobacter pylori infection and iron stores: a systematic review and meta-analysis. Helicobacter 2008;13:323-40.
21. Moayyedi P, Soo S, Deeks J et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006; CD002096.
22. Hsu PI, Lai KH, Lo GH et al. Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients. Gut 2002;51:15-20.
23. Harvey RF, Lane JA, Murray LJ et al. Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter project. BMJ 2004;328:1417-20.
24. Fallone CA, Barkun AN, Mayrand S et al. There is no difference in the disease severity of gastro-oesophageal reflux disease between patients infected and not infected with Helicobacter pylori. Aliment Pharmacol Ther 2004;20:761-8.
25. Nordenstedt H, Nilsson M, Johnsen R et al. Helicobacter pylori infection and gastroesophageal reflux in a populationbased study (The HUNT Study). Helicobacter 2007;12:16-22.
26. Lai KC, Lam SK, Chu KM et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002;346:2033-8.
27. Ricci C, Holton J, Vaira D. Diagnosis of Helicobacter pylori: invasive and non-invasive tests. Best Pract Res Clin Gastroenterol 2007;21:299-313.
28. Gisbert JP, Abraira V. Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis. Am J Gastroenterol 2006;101:848-63.
29. Hojo M, Miwa H, Nagahara A et al. Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection. Scand J Gastroenterol 2001;36:690-700.
30. Fischbach LA, van Zanten S, Dickason J. Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies. Aliment Pharmacol Ther 2004;20:1071-82.
31. Calvet X, Garcia N, Lopez T et al. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection. Aliment Pharmacol Ther 2000;14:603-9.
32. Gisbert JP, Pajares JM. Helicobacter pylori infection and perforated peptic ulcer prevalence of the infection and role of antimicrobial treatment. Helicobacter 2003;8:159-67.